In the highly regulated and demanding pharmaceutical and process industry, cost and efficiency pressure is a constant area of tension. Once equipment has been put into operation at great expense in laboratory or production, it should remain in operation for as long as possible. Unfortunately, older devices and systems in particular only partially or inadequately meet the latest regulatory requirements, meaning that new investments are often necessary. Or do they not?